Cardiovascular implantable electronic device infection: Delayed vs standard FDG PET-CT imaging

Journal of Nuclear Cardiology

Volumn 21, Issue 3, 2014, Pages 622-632

  Leccisotti, Lucia ^a   Perna, Francesco ^a   Lago, Mariaelena ^a   Leo, Milena ^a   Stefanelli, Antonella ^a   Calcagni, Maria L ^a   Pelargonio, Gemma ^a   Narducci, Maria L ^a   Bencardino, Gianluigi ^a   Bellocci, Fulvio ^a   Giordano, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cardiac implantable electronic device; defibrillator; endocarditis; FDG; infection; pacemaker; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; DIAGNOSTIC USE; ENDOCARDITIS; FEMALE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MULTIMODAL IMAGING; PROCEDURES; PROSTHESIS-RELATED INFECTIONS; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TIME;

AGED; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MULTIMODAL IMAGING; PACEMAKER, ARTIFICIAL; POSITRON-EMISSION TOMOGRAPHY; PROSTHESIS-RELATED INFECTIONS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84901648040     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-014-9896-2     Document Type: Article

References (30)

1. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46-53.
2. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, Heart Rhythm Society, American Heart Association, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: This document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6(7):1085-104.
3. Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH, Signore A. The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol 2013. doi:10.1155/2013/623036.
4. Haroon A, Zumla A, Bomanji J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis. 2012;54(9):1333-41.
5. Israel O, Keidar Z. PET/CT imaging in infectious conditions. Ann N Y Acad Sci. 2011;1228:150-66.
6. Glaudemans AW, Signore A. FDG-PET/CT in infections: The imaging method of choice? Eur J Nucl Med Mol Imaging. 2010;37(10):1986-91.
7. Bensimhon L, Lavergne T, Hugonnet F, Mainardi JL, Latremouille C, Maunoury C, et al. Whole body [(18)F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: A preliminary prospective study. Clin Microbiol Infect. 2011;17(6):836-44.
8. Ploux S, Riviere A, Amraoui S, Whinnett Z, Barandon L, Lafitte S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011;8(9):1478-81.
9. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59(18):1616-25.
10. Harisankar CN, Mittal BR, Agrawal KL, Abrar ML, Bhattacharya A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. J Nucl Cardiol. 2011;18(5):926-36.
11. Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol. 2012;59(17):1539-48.
12. Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA, et al. Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging. 2010;3(4):388-97.
13. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105(23):2708-11. (Pubitemid 34615139)
14. Cheng VY, Slomka PJ, Le Meunier L, Tamarappoo BK, Nakazato R, Dey D, et al. Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease. J Nucl Med. 2012;53(4):575-83.
15. Basu S, Alavi A. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: Should these be routinely employed in assessing patients with cancer? Eur J Nucl Med Mol Imaging. 2007;34(10):1527-9. (Pubitemid 47476924)
16. Basu S, Kwee TC, Surti S, Akin EA, Yoo D, Alavi A. Fundamentals of PET and PET/CT imaging. Ann N Y Acad Sci. 2011;1228:1-18.
17. Brinker J. Imaging for infected cardiac implantable electronic devices: A new trick for your pet. J Am Coll Cardiol. 2012;59(18):1626-8.
18. Vos FJ, Bleeker-Rovers CP, van Dijk AP, Oyen WJ. Detection of pacemaker and lead infection with FDG-PET. Eur J Nucl Med Mol Imaging. 2006;33(10):1245. (Pubitemid 44484483)
19. Turpin S, Lambert R, Poirier N. An unusual looking pacemaker infection imaged with 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2010;37(7):1438.
20. Abikhzer G, Turpin S, Bigras JL. Infected pacemaker causing septic lung emboli detected on FDG PET/CT. J Nucl Cardiol. 2010;17(3):514-5.
21. Millar BC, Prendergast BD, Alavi A, Moore JE. Positron emission tomography (PET): A new tool in the diagnosis of endocarditis. Heart. 2009;95(4):332-3.
22. Amraoui S, Texier-Maugein J, Bordachar P. PET scan in suspected but unproven pacemaker endocarditis. Arch Cardiovasc Dis. 2012;105(2):125-6.
23. Cautela J, Alessandrini S, Cammilleri S, Giorgi R, Richet H, Casalta JP, et al. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: A pilot study. Europace. 2013;15(2):252-7.
24. Caldarella C, Leccisotti L, Treglia G, Giordano A. Which is the optimal acquisition time for FDG PET/CT imaging in patients with infective endocarditis? J Nucl Cardiol. 2013;20(2):307-9.
25. Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol. 2013;15(3):345-52.
26. Blomberg BA, Akers SR, Saboury B, Mehta NN, Cheng G, Torigian DA, et al. Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation. Nucl Med Commun. 2013;34(9):860-7.
27. Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44(4):540-8. (Pubitemid 39663420)
28. Jones HA, Cadwallader KA, White JF, Uddin M, Peters AM, Chilvers ER. Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: Implications for interpretation of (18)F-FDG PET images. J Nucl Med. 2002;43(5):652-7. (Pubitemid 34507118)
29. Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T. Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging. 2003;30(2):267-73. (Pubitemid 36686846)
30. Keidar Z, Engel A, Hoffman A, Israel O, Nitecki S. Prosthetic vascular graft infection: The role of 18F-FDG PET/CT. J Nucl Med. 2007;48(8):1230-6. (Pubitemid 47242786)